Riluzole — CAS 58994-96-0

Riluzole is a high-purity Active Pharmaceutical Ingredient (API) classified as a Neuroprotective Agent primarily used for ALS (Amyotrophic Lateral Sclerosis) treatment. Mediocon Inc manufactures GMP-compliant Riluzole at its facility in Aurangabad, Maharashtra, India.

• Amyotrophic lateral sclerosis (ALS / Lou Gehrig's disease)
• Glutamate neurotoxicity inhibition
• Extended survival in ALS patients
• Neuroprotection research in motor neuron disease

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support